Schoenberg Mark

Chief Medical Officer

Schoenberg Mark has filed 10 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.

On the most recent filing, Schoenberg Mark is listed as Chief Medical Officer at UroGen Pharma Ltd. Inside the rolling window, Schoenberg Mark reported no open-market purchases and 8 open-market sales totaling $4.5M in URGN. The largest disclosed transaction in the window is a sale of 60,677 URGN shares on Aug 20, 2026, worth $2.9M.

Companies traded

Other insiders at URGN

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
URGNSale$37KSep 9SEC ↗
URGNSale$2.9MAug 24SEC ↗
URGNSale$400KJul 10SEC ↗
URGNSale$350KJun 24SEC ↗
URGNSale$143KJun 9SEC ↗
URGNSale$300KMay 11SEC ↗
URGNSale$145KFeb 4SEC ↗
URGNSale$250KNov 20SEC ↗
Showing 1–8 of 8
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 8, 2025URGNSale$17K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Schoenberg Mark made?

Schoenberg Mark has filed 10 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.

Which companies does Schoenberg Mark trade?

Schoenberg Mark has filed SEC Form 4 disclosures for 1 company, including URGN.

When was Schoenberg Mark's most recent SEC Form 4 filing?

Schoenberg Mark's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.

What is Schoenberg Mark's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Schoenberg Mark is listed as Chief Medical Officer.

What is Schoenberg Mark's total buy and sell value in the current window?

Inside the rolling retention window, Schoenberg Mark bought $0 and sold $4.5M based on SEC Form 4 filings.

What was Schoenberg Mark's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 60,677 URGN shares on 2026-08-20, worth $2.9M, per SEC Form 4 filings.